Urotensin-II protects against cardiovascular events in patients with kidney disease

被引：0
|
作者：
不详
机构：
来源：
Nature Clinical Practice Nephrology | 2006年 / 2卷 / 7期
关键词：
D O I：
10.1038/ncpneph0196
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：350 / 350
相关论文
共 50 条
  • [31] Oxidative parameters, oxidative DNA damage, and urotensin-II in schizoaffective disorder patients
    Kilic, Osman Hasan Tahsin
    Aksoy, Ihsan
    Elboga, Gulcin Cinpolat
    Bulbul, Feridun
    PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2019, 29 (02) : 151 - 157
  • [32] Urotensin-II, oxidative stress, and inflammation increase in hypertensive and resistant hypertensive patients
    Guler, Eray Metin
    Gokce, Mustafa
    Bacaksiz, Ahmet
    Kocyigit, Abdurrahim
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2021, 43 (03) : 211 - 216
  • [33] Urotensin II is an inverse predictor of death from all causes and cardiovascular events in chronic kidney disease stage 2-5
    Ravani, Pietro
    Tripepi, Gianluigi
    Pecchini, Paola
    Mallamaci, Francesca
    Malberti, Fabio
    Zoccali, Carmine
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 73 - 73
  • [34] Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease
    Zoccali, C
    Mallamaci, F
    Tripepi, G
    Cutrupi, S
    Pizzini, P
    Malatino, L
    KIDNEY INTERNATIONAL, 2006, 69 (07) : 1253 - 1258
  • [35] The urotensin II receptor antagonist, urantide, protects against atherosclerosis in rats
    Zhao, Juan
    Yu, Quan-Xin
    Kong, Wei
    Gao, Hai-Cheng
    Sun, Bo
    Xie, Ya-Qin
    Ren, Li-Qun
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 5 (06) : 1765 - 1769
  • [36] Prevention of Cardiovascular Events in Patients With Chronic Kidney Disease
    Terpening, Chris M. M.
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (12) : 1425 - 1435
  • [37] Novel insights into the role of urotensin II in cardiovascular disease
    Pereira-Castro, Joao
    Bras-Silva, Carmen
    Fontes-Sousa, Ana Patricia
    DRUG DISCOVERY TODAY, 2019, 24 (11) : 2170 - 2180
  • [38] Pharmacokinetics and pharmacodynamics of the urotensin-II receptor antagonist palosuran in macroalbuminuric, diabetic patients.
    Sidharta, PN
    Wagner, FD
    Jungik, A
    Halabi, A
    Dingemanse, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 1078 - 1078
  • [39] The Relationship Between Urotensin-II Level and Carotid Intima Media Thickness in Dialysis Patients
    Buberci, Refika
    Oztekin, Pelin Seher
    Duranay, Murat
    TURKISH JOURNAL OF NEPHROLOGY, 2022, 31 (04): : 328 - 334
  • [40] Increased urotensin-II activity in patients with Raynaud's phenomenon and systemic lupus erythematosus
    Buyukhatipoglu, Hakan
    Buyukaslan, Hasan
    Pehlivan, Yavuz
    Ceylan, Nurdan
    Ulas, Turgay
    Tarakcioglu, Mehmet
    Onat, Ahmet M.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2011, 14 (03) : 276 - 281
12345